Association of noninvasive, radiographic measurement of prostate-specific membrane antigen (PSMA) expression with response to PSMA-targeted radionuclide therapy (TRT).

被引：1

作者：

Vlachostergios, Panagiotis J.

Niaz, Muhammad Junaid

Mosallaie, Seyed Ali

Christos, Paul J.

Hackett, Amy

Osborne, Joseph R.

Jhanwar, Yuliya

Gracey, Lauren

Molina, Ana M.

Nanus, David M.

Bander, Neil Harrison

Tagawa, Scott T.

机构：

[1] Weill Cornell Med Coll, Div Hematol & Med Oncol, New York, NY USA

[2] New York Presbyterian Hosp, New York, NY USA

[3] Weill Cornell Med Coll, New York, NY USA

[4] Weill Cornell Med, Div Nucl Med, New York, NY USA

[5] Weill Cornell Med Coll, Dept Biostat & Epidemiol, New York, NY USA

[6] Cornell Univ, Weill Cornell Med, New York, NY 10021 USA

[7] Weill Cornell Med, New York, NY USA

[8] Sandra & Edward Meyer Canc Ctr, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期

关键词：

D O I：

10.1200/JCO.2019.37.15_suppl.5013

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5013

引用

页数：1

共 50 条

[41] A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Srikanth Boinapally
Hye-Hyun Ahn
Bei Cheng
Mary Brummet
Hwanhee Nam
Kathleen L. Gabrielson
Sangeeta R. Banerjee
Il Minn
Martin G. Pomper
Scientific Reports, 11
[42] A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Boinapally, Srikanth
Ahn, Hye-Hyun
Cheng, Bei
Brummet, Mary
Nam, Hwanhee
Gabrielson, Kathleen L.
Banerjee, Sangeeta R.
Il Minn
Pomper, Martin G.
SCIENTIFIC REPORTS, 2021, 11 (01)
[43] Prostate-specific membrane antigen (PSMA) expression as a potential patient selection marker in patients with refractory solid tumors administered BIND-014, a PSMA-targeted nanoparticle containing docetaxel
Low, Susan
Von Hoff, Daniel
Mita, Monica
Burris, Howard
Eisenberg, Peter
Hart, Lowell
LoRusso, Patricia
Weiss, Glen
Sachdev, Jasgit
Mita, Alain
Ramanathan, Ramesh
Hrkach, Jeff
Summa, Jason
Berk, Gregory
CANCER RESEARCH, 2014, 74 (19)
[44] COMPARISON OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)-TARGETED RADIONUCLIDE THERAPY (TRT) WITH LUTETIUM-177 (177LU) VIA ANTIBODY J591 VS SMALL MOLECULE LIGAND PSMA-617
Niaz, Muhammad Junaid
Skafida, Myrto
Osborne, Joseph
Nanus, David
Molina, Anna
Thomas, Charlene
Vallabhajosula, Shankar
Christos, Paul
Bander, Neil
Tagawa, Scott
JOURNAL OF UROLOGY, 2020, 203 : E367 - E367
[45] Prostate-Specific Membrane Antigen (PSMA) PET: A Counterpart to Prostate MRI
Chen, Christine
Margolis, Daniel
SEMINARS IN ROENTGENOLOGY, 2021, 56 (04) : 376 - 383
[46] Enzymatic activation of prodrugs by prostate-specific membrane antigen (PSMA)
Mhaka, A
Janssen, S
Gady, A
Rosen, M
Denmeade, S
EUROPEAN JOURNAL OF CANCER, 2002, 38 : S36 - S36
[47] Long-term adverse events (AE) in patients with metastatic castration-resistant prostate cancer (mCRPC) receiving prostate-specific membrane antigen (PSMA)-based targeted radionuclide therapy (TRT).
Sun, Michael
Thomas, Charlene
Ho, Benedict
Niaz, Muhammad Junaid
Molina, Ana M.
Sternberg, Cora N.
Nanus, David M.
Bander, Neil Harrison
Tagawa, Scott T.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[48] PROSTATE BIOPSY TARGETED TO PROSTATE SPECIFIC MEMBRANE ANTIGEN (PSMA) FOCI
Kuppermann, David
Calais, Jeremie
Brisbane, Wayne
Tran, Elizabeth
Herbert, Lorna
Benz, Matthias
Czernin, Johannes
Marks, Leonard
JOURNAL OF UROLOGY, 2022, 207 (05): : E144 - E145
[49] New Strategies in Prostate Cancer: Prostate-Specific Membrane Antigen (PSMA) Ligands for Diagnosis and Therapy
Haberkorn, Uwe
Eder, Matthias
Kopka, Klaus
Babich, John W.
Eisenhut, Michael
CLINICAL CANCER RESEARCH, 2016, 22 (01) : 9 - 15
[50] Induction of antibodies against prostate-specific membrane antigen (PSMA) by vaccination with a PSMA DNA vector
Kuratsukuri, K
Wang, CY
Sone, T
Nishisaka, N
Jones, RF
Haas, GP
EUROPEAN UROLOGY, 2002, 42 (01) : 67 - 73

← 1 2 3 4 5 →